Enanta Pharmaceuticals (ENTA) Net Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -5,319.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 10 | Enanta Pharmaceuticals | 405.22 Mn | 215.72 Mn | - | 7,097.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,097.00 |
| Mar 31, 2026 | 13,533.00 |
| Dec 31, 2025 | 5,877.00 |
| Sep 30, 2025 | 671.00 |
| Jun 30, 2025 | 6,306.00 |
| Mar 31, 2025 | 2,777.00 |
| Dec 31, 2024 | -2,251.00 |
| Sep 30, 2024 | -9,224.00 |
| Jun 30, 2024 | -1,498.00 |
| Mar 31, 2024 | -256.00 |
| Dec 31, 2023 | -15,933.00 |
| Sep 30, 2023 | -2,430.00 |
| Jun 30, 2023 | -13,031.00 |
| Mar 31, 2023 | -18,988.00 |
| Dec 31, 2022 | -14,847.00 |
| Sep 30, 2022 | -14,752.00 |
| Jun 30, 2022 | -17,860.00 |
| Mar 31, 2022 | -18,994.00 |
| Dec 31, 2021 | -14,614.00 |
| Sep 30, 2021 | -14,456.00 |